• Cucurbitacin I: A Precision STAT3 Perturbation Guide

  2026-09-16

  Cucurbitacin I, also known as JSI-124, provides a focused way to interrogate JAK2/STAT3 biology in cancer models. This guide combines pathway-level assay design with lessons from human SAN-plexus assembloids to improve mechanistic interpretation without overextending cross-domain evidence.

• Amphotericin B for Fungal Infection Research

  2026-09-16

  Build more informative fungal infection research workflows with Amphotericin B by separating direct membrane damage from biofilm-associated resistance and host-cell signaling. This guide connects dose-response testing, Candida albicans biofilm assays, PP2A–autophagy experiments, and troubleshooting into one practical framework.

• Docetaxel Resistance: From Microtubules to the Microbiome

  2026-09-15

  Docetaxel resistance is not only a problem of microtubule biology. Evidence linking gut dysbiosis, intratumoral lipopolysaccharide, and the NF-κB–IL6–STAT3 axis suggests a broader translational framework for studying Taxotere response. This article outlines how to connect molecular pharmacology, microbiome-aware models, and experimental strategy without overstating early evidence.

• Separating Growth Inhibition from Cell Death in Cancer Model

  2026-09-15

  Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a framework for distinguishing proliferative arrest from actual cell killing while accounting for differences in response magnitude and timing.

• LNP Surface Charge and V-ATPase Drive Delivery

  2026-09-14

  This 2026 study proposes that LNP tropism is determined by a synergy between nanoparticle surface charge and the V-ATPase activity of recipient cells. Its in vitro and in vivo experiments connect cellular endo/lysosomal state with charge-dependent delivery, offering a mechanistic framework for interpreting liver and lung targeting.

• GDC-0941: Reliable PI3K/Akt Assay Workflows

  2026-09-14

  This scenario-driven guide explains how GDC-0941 (SKU A8210) can improve the interpretation and reproducibility of PI3K/Akt pathway inhibition, viability, proliferation, and apoptosis workflows. It covers mechanism, solvent handling, protocol parameters, endpoint selection, and practical vendor evaluation for biomedical laboratories.

• AZD1480: A Translational Compass for JAK2/STAT3

  2026-09-13

  AZD1480 provides a focused way to interrogate tumor-intrinsic JAK2/STAT3 signaling, particularly when immune or metabolic interventions unexpectedly create compensatory survival signals. This thought-leadership guide connects its ATP-competitive pharmacology with biomarker strategy, model selection, combination design, and the limitations that matter for translational oncology.

• LRRC8A–Caveolin-1 Signaling in PDAC

  2026-09-12

  The reference study identifies a cholesterol-dependent LRRC8A–Caveolin-1 complex that links cell-volume regulation with KRAS/EGFR signaling, ribosome biogenesis, and pancreatic ductal adenocarcinoma growth. Its integrated use of genetic perturbation, pharmacological inhibition, xenografts, and patient-derived organoids provides a framework for connecting membrane organization to biosynthetic expansion.

• AZD1390: Decoding ATM Dependence Under G4 Stress

  2026-09-11

  Explore how AZD1390, a selective ATM kinase inhibitor, can distinguish DNA damage signaling from G-quadruplex replication stress. This assay-centered framework supports more rigorous glioblastoma radiosensitization and cancer research.

• Tunicamycin for ER Stress Assay Design

  2026-09-11

  Discover how Tunicamycin functions as an N-glycosylation inhibitor and controlled ER stress model. This guide connects glycosylation blockade with HCV-related insulin-resistance research and practical assay design decisions.

• Bay 11-7821 for NF-κB Assay Design

  2026-09-10

  Bay 11-7821, also called BAY 11-7082, provides a practical pharmacological handle for separating NF-κB-dependent inflammation from macrophage HMGB1 release, apoptosis, and tumor-cell phenotypes. This guide connects inhibitor handling, dose selection, reporter assays, exosome workflows, and troubleshooting to the lactate-driven sepsis biology described in the reference study.

• Phosbind Acrylamide for Phosphorylation Analysis

  2026-09-10

  Phosbind Acrylamide enables antibody-free visualization of phosphorylation-dependent mobility shifts in proteins, supporting faster screening of signaling changes and kinase activity. This workflow translates annexin A2 disease-mechanism findings into practical, paired-gel experiments for protein phosphorylation analysis.

• BMAL1 Phase Separation and Circadian Transcription

  2026-09-09

  Gao et al. identify BMAL1 as a phosphorylation-regulated phase-separating protein that forms dynamic nuclear condensates serving as transcriptional hubs. The study connects BMAL1 intrinsically disordered regions, E-box DNA, transcriptional cofactor recruitment, rhythmic gene expression, and locomotor behavior, while suggesting practical tests for phosphorylation-dependent regulation.

• FITC-Concanavalin A (ConA) Conjugate

  2026-09-09

  FITC-Concanavalin A (ConA) Conjugate is a fluorescent lectin conjugate for visualizing accessible α-D-glucose and α-D-mannose residues on glycoproteins and glycolipids in cell or tissue samples. It supports cell surface carbohydrate detection, immunofluorescence staining, and flow cytometry, but should not be treated as a universal glycan marker or used to identify non-carbohydrate targets.

• Dihydrotestosterone (DHT) Research Guide

  2026-09-08

  This scenario-based guide explains how Dihydrotestosterone (DHT), SKU B8214, can improve experimental interpretation in androgen receptor, viability, proliferation, and signaling assays. It covers solvent compatibility, dose selection, orthogonal readouts, and practical criteria for selecting a reliable research reagent.

7910 records 1/528 page Next 12345 下5页 Last page